Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Mycoses

Retrieve available abstracts of 127 articles:
HTML format

Single Articles

    May 2024
  1. MILANEZ EPR, de Souza PFSM, Monteiro RC, Pereira LMG, et al
    Fusarium keratitis in a Brazilian tropical semi-arid area: Clinical-epidemiological features, molecular identification and antifungal susceptibility.
    Mycoses. 2024;67:e13728.
    PubMed     Abstract available

    April 2024
  2. UHRLASS S, Mey S, Koch D, Mutze H, et al
    Dermatophytes and skin dermatophytoses in Southeast Asia-First epidemiological survey from Cambodia.
    Mycoses. 2024;67:e13718.
    PubMed     Abstract available

  3. WANG S, Chen W, Liu F, Li R, et al
    Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non-psoriatic patients: A prospective study.
    Mycoses. 2024;67:e13721.
    PubMed     Abstract available

  4. CONSUEGRA-ASPRILLA JM, Rodriguez-Echeverri C, Posada DH, Gomez BL, et al
    Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells.
    Mycoses. 2024;67:e13720.
    PubMed     Abstract available

  5. QU Y, Feng Y, Bian S, Yang Y, et al
    Low toxicity contributes to Sporothrix globosa invade the skin of patients in low-epidemic areas of China.
    Mycoses. 2024;67:e13724.
    PubMed     Abstract available

  6. GUPTA AK, Wang T, Polla Ravi S, Mann A, et al
    Global prevalence of onychomycosis in general and special populations: An updated perspective.
    Mycoses. 2024;67:e13725.
    PubMed     Abstract available

    March 2024
  7. SCHALLER M, Walker B, Nabhani S, Odon A, et al
    Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis-Results of an in vitro investigation.
    Mycoses. 2024;67:e13710.
    PubMed     Abstract available

  8. DANTAS MDS, Cintra MEC, Lucini F, Venturini J, et al
    CARD9 mutations in patients with fungal infections: An update from the last 5 years.
    Mycoses. 2024;67:e13712.
    PubMed     Abstract available

  9. ZANG F, Wang Z, Yang Y, Xiao Z, et al
    Responses of keratinocytes to Trichophyton mentagrophyte infection based on whole transcriptome analysis.
    Mycoses. 2024;67:e13713.
    PubMed     Abstract available

  10. BHAT RM, Madhumita M, Marla NJ, Jayaraman J, et al
    Immunohistochemical analysis of chronic and recurrent dermatophytosis.
    Mycoses. 2024;67:e13714.
    PubMed     Abstract available

    February 2024
  11. DE OLIVEIRA VF, Petrucci JF, Taborda M, Brener PZ, et al
    Clinical characteristics, diagnosis, and treatment of central nervous system sporotrichosis: Systematic review and meta-analysis.
    Mycoses. 2024;67:e13697.
    PubMed     Abstract available

  12. PARIHAR R, Singh U, Das A, Baishya B, et al
    Identification of primary metabolites in fungal species of Trichophyton mentagrophyte and Trichophyton rubrum by NMR spectroscopy.
    Mycoses. 2024;67:e13699.
    PubMed     Abstract available

  13. BALASUBRAMANIAN A, Akbar Ali NA, Pugazhenthi A, Gopalan K, et al
    A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India.
    Mycoses. 2024;67:e13707.
    PubMed     Abstract available

  14. NOKDHES YN, Leeyaphan C, Jirawattanadon P, Pongkittilar B, et al
    Prevalence and characteristics of Epidermophyton floccosum skin infections: A 12-year retrospective study.
    Mycoses. 2024;67:e13702.
    PubMed     Abstract available

    January 2024
  15. JEON JJ, Kim YH, Lim SH, Lee S, et al
    Comparing the diagnostic accuracy of PCR-reverse blot hybridization assay and conventional fungus study in superficial fungal infection of the skin: A systematic review.
    Mycoses. 2024;67:e13678.
    PubMed     Abstract available

  16. LUO Y, Tang JF, Gao FF, Quan JH, et al
    NLRP3 regulates CIITA/MHC II axis and interferon-gamma-inducible chemokines in Malassezia globosa-infected keratinocytes.
    Mycoses. 2024;67:e13680.
    PubMed     Abstract available

  17. GUPTA AK, Elewski B, Joseph WS, Lipner SR, et al
    Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents.
    Mycoses. 2024;67:e13683.
    PubMed     Abstract available

  18. RANA DK, Shah TS, Rohit MH, Patel NH, et al
    Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.
    Mycoses. 2024;67:e13681.
    PubMed     Abstract available

  19. NAVARRO-PEREZ D, Garcia-Oreja S, Tardaguila-Garcia A, Leon-Herce D, et al
    Inter-observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases.
    Mycoses. 2024;67:e13694.
    PubMed     Abstract available

  20. IBRAHIM AM, Ibrahim NS, Elgharabawy ES, Morsi HM, et al
    Efficacy of topical trichloroacetic acid 100% either alone or combined with topical tioconazole 28% versus systemic itraconazole in the treatment of onychomycosis.
    Mycoses. 2024;67:e13690.
    PubMed     Abstract available

  21. CHIRIAC A, Diaconeasa A, Voicu C, Ivaniciuc M, et al
    Kerion Celsi in infants and children-A narrative review 2010-2023.
    Mycoses. 2024;67:e13675.
    PubMed     Abstract available

  22. STARACE M, Milan E, Summa G, Alessandrini AM, et al
    Onychoscopic characteristics of Trichophyton rubrum and Trichophyton interdigitalis fungal infections: A multicentric study.
    Mycoses. 2024;67:e13673.
    PubMed     Abstract available

  23. FAELI L, Kermani F, Rezaei-Matehkolaei A, Ilkit M, et al
    Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non-transcribed spacer region of rDNA and antifungal susceptibility testing of the species.
    Mycoses. 2024;67:e13666.
    PubMed     Abstract available

  24. GUERRERO-PONCE AE, Araiza J, Tirado-Sanchez A, Bonifaz A, et al
    Review Article White Piedra: Review of 131 cases.
    Mycoses. 2024;67:e13668.
    PubMed     Abstract available

  25. LIU YY, Song Y, Guan MQ, Yang L, et al
    Hyperthermia is a promising potential adjunct to treating sporotrichosis: A refractory case of HIV sporotrichosis and in vitro experiments on Sporothrix spp.
    Mycoses. 2024;67:e13671.
    PubMed     Abstract available

  26. SONG G, Kong X, Li X, Liu W, et al
    Prior selection of itraconazole in the treatment of recalcitrant Trichophyton indotineae infection: Real-world results from retrospective analysis.
    Mycoses. 2024;67:e13663.
    PubMed     Abstract available

  27. NYUYKONGE B, Siddig EE, Nyaoke BA, Zijlstra EE, et al
    Using (1,3)-beta-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis.
    Mycoses. 2024;67:e13664.
    PubMed     Abstract available

  28. RAMZY B, Emily AH, Jiryis B, Ziad K, et al
    Nd:YAG 1064 nm laser treatment for onychomycosis - is it really effective? A prospective assessment for efficiency and factors contributing to response.
    Mycoses. 2024;67:e13657.
    PubMed     Abstract available

  29. GOMEZ C, Schuele G, Alberdi E
    Medium-term antifungal effects of methylene blue versus flavin mononucleotide in the treatment of moderate toenail onychomycosis.
    Mycoses. 2024;67:e13661.
    PubMed     Abstract available

  30. ROSTER K, Wang Y, Lipner SR
    Retrospective analysis of onychomycosis prescribing patterns using the medicare part D prescribers database 2016-2020.
    Mycoses. 2024;67:e13660.
    PubMed     Abstract available

  31. PATHANIA YS, Cds K, Kumar A
    Comparing emollient use with topical luliconazole (azole) in the maintenance of remission of chronic and recurrent dermatophytosis. An open-label, randomized prospective active-controlled non-inferiority study.
    Mycoses. 2024;67:e13659.
    PubMed     Abstract available

  32. MAGALHAES VCR, Colombo SA, Peres NTA, Moura AS, et al
    Clinical factors associated with systemic sporotrichosis in Brazil.
    Mycoses. 2024;67:e13656.
    PubMed     Abstract available

  33. HAGHANI I, Hedayati MT, Shokohi T, Kermani F, et al
    Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment.
    Mycoses. 2024;67:e13652.
    PubMed     Abstract available

  34. BOMBASSARO A, Figueiredo JM, Taborda CP, Joosten LAB, et al
    Skin innate immune response against fungal infections and the potential role of trained immunity.
    Mycoses. 2024;67.
    PubMed     Abstract available

    December 2023
  35. KASSEM R, Barzilai A, Baum S, Kempfner A, et al
    Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.
    Mycoses. 2023;66:1064-1070.
    PubMed     Abstract available

  36. LEHRER S, Rheinstein PH
    Association of Kallikrein Related Peptidase 3 (KLK3) gene with dermatophytosis in the UK biobank cohort.
    Mycoses. 2023;66:1050-1055.
    PubMed     Abstract available

  37. NAVARRO-PEREZ D, Garcia-Oreja S, Tardaguila-Garcia A, Leon-Herce D, et al
    Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients.
    Mycoses. 2023;66:1045-1049.
    PubMed     Abstract available

    November 2023
  38. BORBA OSM, Ogawa MM, Kirsztajn GM, Tomimori J, et al
    Onychomycosis in immunocompromised population: Phenotypic and molecular identification.
    Mycoses. 2023;66:1018-1024.
    PubMed     Abstract available

    October 2023
  39. COLOMBO SA, Bicalho GC, de Oliveira CSF, de Magalhaes Soares DF, et al
    Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease.
    Mycoses. 2023;66:911-922.
    PubMed     Abstract available

  40. DA COSTA B, Pippi B, Merkel S, Agostinetto G, et al
    Drosophila melanogaster as a model of systemic dermatophytosis.
    Mycoses. 2023;66:906-910.
    PubMed     Abstract available

  41. POESTER VR, Munhoz LS, Stevens DA, Melo AM, et al
    Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis.
    Mycoses. 2023;66:898-905.
    PubMed     Abstract available

  42. TAIBO A, Seoane Estevez A, Martinez Campayo N, Rodriguez Mayo M, et al
    Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain.
    Mycoses. 2023;66:891-897.
    PubMed     Abstract available

  43. UEMURA EVG, Rossato L
    Sporotrichosis co-infection with human immunodeficiency virus/acquired immunodeficiency syndrome.
    Mycoses. 2023;66:845-853.
    PubMed     Abstract available

  44. FULGENCE KK, Marie KPC, Akoua VB, Massafoma KEG, et al
    Dermatophytosis and the associated risk factors among primary school children in southern and central Cote d'Ivoire.
    Mycoses. 2023;66:869-875.
    PubMed     Abstract available

  45. DEV PP, Bansal S, Bhargava A
    Revisiting the pathogenesis of dermatophytosis: A cross-sectional analytic study of serum levels of interleukins-2, 8, 10 and 17.
    Mycoses. 2023;66:876-881.
    PubMed     Abstract available

    September 2023
  46. LIETZ A, Eckel F, Kiss H, Noe-Letschnig M, et al
    Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study.
    Mycoses. 2023;66:767-773.
    PubMed     Abstract available

    August 2023
  47. DE FREITAS VLT, Rocha FMM, Ribeiro EN, Lindoso JAL, et al
    Seasonality of sporotrichosis in Brazil: A modelled analysis of the epidemic in Sao Paulo, 2011-2020.
    Mycoses. 2023;66:643-650.
    PubMed     Abstract available

  48. LIN L, Huang J, Fang J, Li J, et al
    Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
    Mycoses. 2023;66:651-658.
    PubMed     Abstract available

  49. MOHOREA-NEATA AL, Ghita MC, Moroti R, Ghiaur A, et al
    Invasive fusariosis in acute leukaemia patients-An outbreak in the haematology ward.
    Mycoses. 2023;66:705-710.
    PubMed     Abstract available

    July 2023
  50. BOMBASSARO A, Spruijtenburg B, Medeiros F, Jacomel Favoreto de Souza Lima B, et al
    Genotyping and antifungal susceptibility testing of Sporothrix brasiliensis isolates from Southern Brazil.
    Mycoses. 2023;66:585-593.
    PubMed     Abstract available

  51. ZALACAIN-VICUNA AJ, Nieto C, Picas J, Martinez H, et al
    Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.
    Mycoses. 2023;66:566-575.
    PubMed     Abstract available

    June 2023
  52. THAMMASIT P, Laliam A, Chaicumpar K, Pruksaphon K, et al
    Differential lipase virulence in Malassezia furfur dimorphism isolated from pityriasis versicolor patients and healthy individuals.
    Mycoses. 2023;66:540-549.
    PubMed     Abstract available

  53. NAVARRO-PEREZ D, Tardaguila-Garcia A, Garcia-Oreja S, Lopez-Moral M, et al
    Onychomycosis associated with diabetic foot syndrome: A systematic review.
    Mycoses. 2023;66:459-466.
    PubMed     Abstract available

  54. LEEYAPHAN C, Chai-Adisaksopha C, Tovanabutra N, Phinyo P, et al
    Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study.
    Mycoses. 2023;66:497-504.
    PubMed     Abstract available

  55. SIDDIG EE, Ahmed A, Hassan OB, Bakhiet SM, et al
    Using a Madurella mycetomatis-specific PCR on grains obtained via non-invasive fine-needle aspirated material is more accurate than cytology.
    Mycoses. 2023;66:477-482.
    PubMed     Abstract available

    May 2023
  56. WEI W, He X, Bao X, Wang G, et al
    Application of deep learning algorithm in the recognition of cryptococcosis and talaromycosis skin lesions.
    Mycoses. 2023 May 3. doi: 10.1111/myc.13598.
    PubMed     Abstract available

  57. SONG G, Zhang M, Liu W, Liang G, et al
    Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment.
    Mycoses. 2023;66:448-454.
    PubMed     Abstract available

  58. FIRKUS D, Abu Saleh OM, Enzler MJ, Jannetto PJ, et al
    Does metabolite matter? Defining target itraconazole and hydroxy-itraconazole serum concentrations for blastomycosis.
    Mycoses. 2023;66:412-419.
    PubMed     Abstract available

  59. PILZ JF, Koberle M, Kain A, Seidl P, et al
    Increasing incidence of Trichophyton tonsurans in Munich-A single-centre observation.
    Mycoses. 2023;66:441-447.
    PubMed     Abstract available

  60. SIDDIG EE, Nyuykonge B, Mhmoud NA, Abdallah OB, et al
    Comparing the performance of the common used eumycetoma diagnostic tests.
    Mycoses. 2023;66:420-429.
    PubMed     Abstract available

    April 2023
  61. ZHU H, Xia X, Zhi H, Shen H, et al
    Retrospective analysis of 71 patients with cutaneous sporotrichosis.
    Mycoses. 2023 Apr 10. doi: 10.1111/myc.13588.
    PubMed     Abstract available

  62. BHAT RM, Madhumita M, Jayaraman J
    Dermatophytoses Severity Score - A novel point-of-care scoring tool to assess the severity of dermatophytosis.
    Mycoses. 2023;66:354-361.
    PubMed     Abstract available

  63. ZHOU X, Liu W, Yang S, Wu A, et al
    Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases.
    Mycoses. 2023;66:338-345.
    PubMed     Abstract available

  64. BHALAVI H, Shaw D, Mehta H, Narang T, et al
    Correlation of plasma levels of itraconazole with treatment response at 4 weeks in chronic dermatophytosis: Results of a randomised controlled trial.
    Mycoses. 2023;66:281-288.
    PubMed     Abstract available

    March 2023
  65. NOSRATABADI M, Faeli L, Haghani I, Mohammadi R, et al
    In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.
    Mycoses. 2023;66:258-275.
    PubMed     Abstract available

  66. PARK H, Bae S, Kim MJ, Chong YP, et al
    Clinical characteristics and outcomes of invasive and non-invasive fusariosis in South Korea.
    Mycoses. 2023;66:211-218.
    PubMed     Abstract available

    February 2023
  67. FERREIRA VOIDALESKI M, de Fatima Costa F, de Hoog GS, Gomes RR, et al
    Metagenomics reveals an abundance of black yeast-like fungi in the skin microbiome.
    Mycoses. 2023 Feb 5. doi: 10.1111/myc.13574.
    PubMed     Abstract available

  68. GALILI E, Goldsmith T, Khanimov I, Arbel C, et al
    Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response.
    Mycoses. 2023;66:144-149.
    PubMed     Abstract available

    January 2023
  69. BATVANDI A, Pchelin IM, Kiasat N, Kharazi M, et al
    Time and cost-efficient identification of Trichophyton indotineae.
    Mycoses. 2023;66:75-81.
    PubMed     Abstract available

  70. MOSELEY I, Ragi SD, Ouellette S, Rao B, et al
    Tinea pedis in underrepresented groups: All of Us database analysis.
    Mycoses. 2023;66:29-34.
    PubMed     Abstract available

    December 2022
  71. NYUYKONGE B, Siddig EE, Mhmoud NA, Nyaoke BA, et al
    Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Mycoses. 2022;65:1170-1178.
    PubMed     Abstract available

  72. KHATTAB F, Elkholy BM, Taha M, Abd-Elbaset A, et al
    Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Mycoses. 2022;65:1194-1201.
    PubMed     Abstract available

  73. KOCH C, Nordzieke S, Grieger J, Mayser P, et al
    Medium-chain fatty acid esters are effective even in azole-resistant Malassezia pachydermatis.
    Mycoses. 2022;65:1188-1193.
    PubMed     Abstract available

  74. GUEVARA A, Nery AF, de Souza Carvalho Melhem M, Bonfietti L, et al
    Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
    Mycoses. 2022;65:1146-1158.
    PubMed     Abstract available

  75. DI VITO M, Scafuro C, Mariotti M, Garzoli S, et al
    Green natural nail polish modified with essential oils to treat onychomycosis.
    Mycoses. 2022;65:1127-1136.
    PubMed     Abstract available

  76. YILMAZ A, Goktay F, Varol R, Gencoglan G, et al
    Deep convolutional neural networks for onychomycosis detection using microscopic images with KOH examination.
    Mycoses. 2022;65:1119-1126.
    PubMed     Abstract available

  77. MUNHOZ LS, Poester VR, Severo CB, Trapaga MR, et al
    Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil.
    Mycoses. 2022;65:1112-1118.
    PubMed     Abstract available

    November 2022
  78. HAGHANI I, Shams-Ghahfarokhi M, Dalimi Asl A, Shokohi T, et al
    Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum-equiseti species complexes from onychomycosis in north of Iran.
    Mycoses. 2022;65:1030-1039.
    PubMed     Abstract available

    October 2022
  79. COGNIALLI R, Bloss K, Weiss I, Caceres DH, et al
    A lateral flow assay for the immunodiagnosis of human cat-transmitted sporotrichosis.
    Mycoses. 2022;65:926-934.
    PubMed     Abstract available

  80. NIODE NJ, Suling PL, Adji A, Miranda E, et al
    Clinico-laboratory findings of Malassezia folliculitis in Indonesia: A multicentre study.
    Mycoses. 2022;65:953-959.
    PubMed     Abstract available

  81. DE OLIVEIRA GV, Maia MLP, Leao FAA, Sad EF, et al
    What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature.
    Mycoses. 2022;65:918-925.
    PubMed     Abstract available

  82. XIA H, Mo XH, Yang LJ, Yang H, et al
    Comparison of samples of blister fluid and scales in the diagnosis of dermatomycosis.
    Mycoses. 2022;65:969-975.
    PubMed     Abstract available

    September 2022
  83. PATEL N, Padhiyar J, Singh R, Bloch A, et al
    Comparative evaluation of host immune response and cytokine signature pertaining to Th1 and Th2 immune arms in serum and tissue among patients of acute localised vs. chronic disseminated dermatophytosis.
    Mycoses. 2022;65:877-886.
    PubMed     Abstract available

    July 2022
  84. POWELL J, Porter E, Field S, O'Connell NH, et al
    Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.
    Mycoses. 2022;65:770-779.
    PubMed     Abstract available

  85. SKAASTRUP KN, Astvad KMT, Arendrup MC, Jemec GBE, et al
    Disinfection trials with terbinafine-susceptible and terbinafine-resistant dermatophytes.
    Mycoses. 2022;65:741-746.
    PubMed     Abstract available

    June 2022
  86. RONG T, Zhu P, Zhou Y, Li Q, et al
    Altered skin fungal and bacterial community compositions in tinea capitis.
    Mycoses. 2022 Jun 11. doi: 10.1111/myc.13480.
    PubMed     Abstract available

  87. EGGER M, Hoenigl M, Thompson GR 3rd, Carvalho A, et al
    Let's talk about sex characteristics-As a risk factor for invasive fungal diseases.
    Mycoses. 2022;65:599-612.
    PubMed     Abstract available

  88. FUHR R, Cook D, Ridden J, Nield K, et al
    Results from a Phase 1/2 trial of BB2603, a terbinafine-based topical nano-formulation, in onychomycosis and tinea pedis.
    Mycoses. 2022;65:661-669.
    PubMed     Abstract available

  89. NYUYKONGE B, Lim W, van Amelsvoort L, Bonifaz A, et al
    Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Mycoses. 2022;65:650-655.
    PubMed     Abstract available

    May 2022
  90. ZIAKA M, Papakonstantinou E, Vasileiou E, Chorafa E, et al
    Pediatric cutaneous mucormycosis: case report and review of the literature.
    Mycoses. 2022 May 5. doi: 10.1111/myc.13452.
    PubMed     Abstract available

  91. ATSU N, Ergin C, Caf N, Turkoglu Z, et al
    Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples.
    Mycoses. 2022 May 4. doi: 10.1111/myc.13450.
    PubMed     Abstract available

  92. CORREIA NS, Balbinot RTS, Bonacorsi C, Donofrio FC, et al
    Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015-2020.
    Mycoses. 2022;65:560-566.
    PubMed     Abstract available

    April 2022
  93. ZHU X, Zheng B, Cai W, Zhang J, et al
    Deep learning-based diagnosis models for onychomycosis in dermoscopy.
    Mycoses. 2022;65:466-472.
    PubMed     Abstract available

  94. NASR M, Abd-Elhamid N, Abd-Allah D, Elkholy B, et al
    Acitretin: Could it be a new therapeutic player in the field of onychomycosis?
    Mycoses. 2022;65:402-410.
    PubMed     Abstract available

  95. SONG G, Zhang M, Liu W, Liang G, et al
    Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020.
    Mycoses. 2022;65:440-448.
    PubMed     Abstract available

  96. BLUME-PEYTAVI U, Tosti A, Falques M, Tamarit ML, et al
    A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
    Mycoses. 2022;65:392-401.
    PubMed     Abstract available

    March 2022
  97. WIDATY S, Oktarina C, Suling PL, Niode NJ, et al
    Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia.
    Mycoses. 2022;65:323-330.
    PubMed     Abstract available

  98. TRAVE I, Cozzani E, Canepa P, Verdiani S, et al
    Real-life applicability of the Euroarray dermatomycosis kit in the diagnosis of onychomycosis.
    Mycoses. 2022;65:317-322.
    PubMed     Abstract available

    February 2022
  99. VILLACORTA CARI E, Leedy N, Ribes JA, Soria J, et al
    Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients.
    Mycoses. 2022;65:239-246.
    PubMed     Abstract available

    January 2022
  100. WANG S, Song Y, Wan Z, Chen W, et al
    Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis.
    Mycoses. 2022;65:35-44.
    PubMed     Abstract available

  101. POESTER VR, Stevens DA, Basso RP, Munhoz LS, et al
    CATastrophe: Response to the challenges of zoonotic sporotrichosis in southern Brazil.
    Mycoses. 2022;65:30-34.
    PubMed     Abstract available

  102. SHENOY MM, Rengasamy M, Dogra S, Kaur T, et al
    A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.
    Mycoses. 2022;65:13-23.
    PubMed     Abstract available

    December 2021
  103. KHURANA A, Agarwal A, Singh A, Sardana K, et al
    Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
    Mycoses. 2021;64:1480-1488.
    PubMed     Abstract available

  104. LAROCHE L, Bourgeois N, Lachaud L, Rispail P, et al
    Epidemiological analysis of nail aspergillosis and non-dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France (1991-2019).
    Mycoses. 2021;64:1546-1553.
    PubMed     Abstract available

  105. GUARANA M, Nouer SA, Nucci M
    EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis.
    Mycoses. 2021;64:1542-1545.
    PubMed     Abstract available

  106. HE M, Zeng J, Mao Y, Zheng Y, et al
    Aetiological changes of tinea capitis in the Hubei area in 60 years: Focus on adult tinea capitis.
    Mycoses. 2021;64:1527-1534.
    PubMed     Abstract available

    November 2021
  107. RONG T, Li R, Ruojun W
    Dysbiosis of Skin Mycobiome in Atopic Dermatitis.
    Mycoses. 2021 Nov 24. doi: 10.1111/myc.13402.
    PubMed     Abstract available

  108. ELSNER K, Holstein J, Hilke FJ, Blumenstock G, et al
    Prevalence of Candida species in Psoriasis.
    Mycoses. 2021 Nov 17. doi: 10.1111/myc.13399.
    PubMed     Abstract available

  109. ZHANG W, Wu S, Wang X, Gao Y, et al
    Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis-A Six-year Retrospective Cohort Study.
    Mycoses. 2021;64:1422-1428.
    PubMed     Abstract available

  110. JHA K, Shaw D, Karim A, Narang T, et al
    Immunological response and clinical profile in patients with recurrent dermatophytosis.
    Mycoses. 2021;64:1429-1441.
    PubMed     Abstract available

  111. JAIN A, Dhamale S, Sardesai V
    Factors responsible for difficult to treat superficial fungal infections: A study from a tertiary healthcare centre in India.
    Mycoses. 2021;64:1442-1447.
    PubMed     Abstract available

  112. SHAMSIZADEH F, Ansari S, Zarei Mahmoudabadi A, Hubka V, et al
    In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin.
    Mycoses. 2021;64:1378-1386.
    PubMed     Abstract available

    October 2021
  113. SHARMA B, Nonzom S
    Novel cases of cutaneous phaeohyphomycosis by Alternaria alstromeriae, Epicoccum tritici and Phialemonium obovatum from North India.
    Mycoses. 2021 Oct 3. doi: 10.1111/myc.13378.
    PubMed     Abstract available

  114. NOWICKA D, Nawrot U
    Tinea pedis-An embarrassing problem for health and beauty-A narrative review.
    Mycoses. 2021;64:1140-1150.
    PubMed     Abstract available

  115. ZHAO Y, Gan M, Li L, Su H, et al
    Majocchi's granuloma: Autoinoculation and adaption of Trichophyton rubrum with molecular evidence.
    Mycoses. 2021;64:1272-1278.
    PubMed     Abstract available

    September 2021
  116. BADIANE AS, Diongue K, Seck MC, Ndiaye M, et al
    Epidemiological aspects of superficial fungal infections in Koranic schools in two localities of Senegal (Thies and Touba).
    Mycoses. 2021;64:1132-1136.
    PubMed     Abstract available

    August 2021
  117. METIN MS, Elmas OF, Demirbas A, Erel O, et al
    The role of oxidative stress in onychomycosis: Thiol/disulphide homeostasis.
    Mycoses. 2021;64:947-953.
    PubMed     Abstract available

  118. GNAT S, Dylag M, Lagowski D, Zielinski J, et al
    Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams.
    Mycoses. 2021;64:967-975.
    PubMed     Abstract available

  119. SHAW D, Ghosh AK, Paul S, Singh S, et al
    Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry: Protocol standardisation, comparison and database expansion for faster and reliable identification of dermatophytes.
    Mycoses. 2021;64:926-935.
    PubMed     Abstract available

  120. SHARMA B, Nonzom S
    Superficial mycoses, a matter of concern: Global and Indian scenario-an updated analysis.
    Mycoses. 2021;64:890-908.
    PubMed     Abstract available

  121. CHANG MJ, Qiu Y, Lipner SR
    Race reporting and representation in onychomycosis clinical trials: A systematic review.
    Mycoses. 2021;64:954-966.
    PubMed     Abstract available

    July 2021
  122. PHAM CVA, Rademacher F, Hinrichs H, Beck-Jendroschek V, et al
    Expression of epidermal antimicrobial peptides is increased in tinea pedis.
    Mycoses. 2021;64:763-770.
    PubMed     Abstract available

  123. DA COSTA B, Pippi B, Berlitz SJ, Carvalho AR, et al
    Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis.
    Mycoses. 2021;64:727-733.
    PubMed     Abstract available

  124. SINGH A, Singh P, Dingemans G, Meis JF, et al
    Evaluation of DermaGenius((R)) resistance real-time polymerase chain reaction for rapid detection of terbinafine-resistant Trichophyton species.
    Mycoses. 2021;64:721-726.
    PubMed     Abstract available

  125. ABDILLAH A, Packeu A, Khelaifia S, Ranque S, et al
    Intra- and inter-laboratory comparison of mDixon and FastFung broths for Malassezia antifungal susceptibility testing.
    Mycoses. 2021;64:716-720.
    PubMed     Abstract available

  126. BADALI H, Canete-Gibas C, Patterson H, Sanders C, et al
    In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Mycoses. 2021;64:748-752.
    PubMed     Abstract available

  127. REINEL D
    Non-dermatophyte fungi in onychomycosis-Epidemiology and consequences for clinical practice.
    Mycoses. 2021;64:694-700.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.